Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Use of functional magnetic resonance imaging in the early identification of Alzheimer's disease.

Neuropsychology review - 1 Jun 2007

Wierenga Christina E, Bondi Mark W

Abstract excerpt

A growing body of evidence suggests that a preclinical phase of Alzheimer's disease (AD) exists several years or more prior to the overt manifestation of clinical symptoms and is characterized by subtle neuropsychological and brain changes. Identification of individuals prior to the development of significant clinical symptoms is imperative in order to have the greatest treatment impact by maintaining cognitive...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apolipoprotein E4
Share to Cognition Disorders
Share to Diffusion Magnetic Resonance Imaging

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Early Diagnosis

Share to Image Processing, Computer-Assisted

Share to Neuropsychological Tests

Share to Oxygen Consumption

Share to Sensitivity and Specificity

Source

Open in PubMed Open full text

Identifiers

PMID: 17476598
DOI: 10.1007/s11065-007-9025-y
PMCID: PMC2084460

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Use of functional magnetic resonance imaging in the early identification of Alzheimer's disease.PMID 17476598Read ↗

Early detection of Alzheimer's disease using neuroimaging.Semantic proximity Read ↗

Magnetic Resonance Imaging to Detect Early Molecular and Cellular Changes in Alzheimer's DiseaseSemantic proximity Read ↗

Identification of Alzheimer disease risk by functional magnetic resonance imaging.Semantic proximity Read ↗

The Utility of Cerebral Blood Flow as a Biomarker of Preclinical Alzheimer's Disease.Semantic proximity Read ↗

Early diagnosis of Alzheimer dementia based on clinical and biological factors.Semantic proximity Read ↗

Neuroimaging within the Dominantly Inherited Alzheimer’s Network (DIAN): PET and MRISemantic proximity Read ↗

Preclinical Alzheimer disease-the challenges ahead.Semantic proximity Read ↗

Discriminant analysis of brain imaging data identifies subjects with early Alzheimer's disease.Semantic proximity Read ↗

Early diagnosis of Alzheimer's disease: contribution of structural neuroimaging.Semantic proximity Read ↗

Functional brain imaging to identify affected subjects genetically at risk for Alzheimer's disease.Semantic proximity Read ↗

Use of neuroimaging to detect early brain changes in people at genetic risk for Alzheimer's disease.Semantic proximity Read ↗

Neuroimaging and genetic assessment for early diagnosis of Alzheimer's disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.